We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Medicinal Products

1017. Deputy David Cullinane asked the Minister for Health whether patients granted ministerial licences outside the three conditions covered by the Medical Cannabis Access Programme can receive HSE funding to cover costs of their medicine; and whether funding is covered for persons with conditions on the long- term illness scheme. [79657/26]

Comment on this

The Pharmacy Function section of the Primary Care Reimbursement Service (PCRS) confirms approval to the Travel Abroad Unit of the HSE office to pay the dispensing pharmacy in the Netherlands for approved prescriptions under the Ministerial Licence System for the three stated conditions that are covered by the Medical Cannabis Access Programme, namely:

• Refractory Epilepsy

• Spasticity as a result of Multiple Sclerosis

• Nausea as a result of chemotherapy.

The Long-Term Illness (LTI) Scheme was established under Section 59(3) of the Health Act 1970 (as amended). Regulations were made in 1971, 1973 and 1975, prescribing 16 conditions to be covered by the Scheme. The Ministerial Licence treatment is not covered by the LTI Scheme.

Comment on this